Jim Simons
VTGN icon

Jim Simons’s VistaGen Therapeutics VTGN Stock Holding History

Jim Simons’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Buy
291,300
+130,509
+81% +$79.3K ﹤0.01% 2946
2025
Q4 		$106K Sell
160,791
-261,221
-62% -$944K ﹤0.01% 2998
2025
Q3 		$1.5M Buy
422,012
+381,512
+942% +$1.14M ﹤0.01% 2258
2025
Q2 		$81K Buy
40,500
+15,700
+63% +$35.7K ﹤0.01% 3332
2025
Q1 		$62K Sell
24,800
-58,900
-70% -$167K ﹤0.01% 3267
2024
Q4 		$247K Sell
83,700
-106,900
-56% -$301K ﹤0.01% 3102
2024
Q3 		$574K Buy
190,600
+125,700
+194% +$429K ﹤0.01% 2726
2024
Q2 		$226K Sell
64,900
-44,900
-41% -$194K ﹤0.01% 3006
2024
Q1 		$580K Buy
+109,800
New +$528K ﹤0.01% 2801
2023
Q1 		– Sell
-3,493
Closed -$11K – 4440
2022
Q4 		$11K Sell
3,493
-121,919
-97% -$459K ﹤0.01% 4032
2022
Q3 		$572K Buy
125,412
+97,725
+353% +$969K ﹤0.01% 2848
2022
Q2 		$731K Sell
27,687
-11,596
-30% -$409K ﹤0.01% 2909
2022
Q1 		$1.46M Buy
+39,283
New +$1.71M ﹤0.01% 2455
2021
Q3 		– Sell
-3,421
Closed -$323K – 3880
2021
Q2 		$323K Buy
+3,421
New +$253K ﹤0.01% 3123
2021
Q1 		– Sell
-27,833
Closed -$1.62M – 3748
2020
Q4 		$1.62M Buy
27,833
+23,700
+573% +$605K ﹤0.01% 2251
2020
Q3 		$86K Buy
4,133
+3,735
+938% +$77.3K ﹤0.01% 3232
2020
Q2 		$6K Buy
+398
New +$5.44K ﹤0.01% 3384

Other funds holding VTGN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jim Simons's VTGN Position: Q1 2026 in Review

Jim Simons increased its VistaGen Therapeutics (VTGN) stake by 81% in Q1 2026, buying an estimated $79.3K and bringing the position to 291,300 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Jim Simons first reported a position in VTGN in Q2 2020 and has held it in 17 quarters since. The position peaked at $1.62M in Q4 2020. 56 funds tracked by Wall St. Rank hold VTGN as of Q1 2026.

  • Jim Simons held 291,300 shares of VistaGen Therapeutics worth $166K as of Q1 2026.
  • Jim Simons bought 130,509 VistaGen Therapeutics shares in Q1 2026, an estimated $79.3K.
  • VistaGen Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2946 holding.
  • Jim Simons first reported a position in VistaGen Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • Jim Simons's VistaGen Therapeutics position peaked at $1.62M in Q4 2020.
  • 56 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.